Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
EV/Core EBITDA

    Back to All Ratios
SHREE GANESH REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Core EBITDA(x) 12.6616.3921.084.344.88

What is the latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES ?

The latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES is 12.66 based on Mar2023 Standalone results.
Year EV/Core EBITDA
Mar202312.66
Mar202216.39
Mar202121.08
Mar20204.34
Mar20194.88

How is EV/Core EBITDA of SHREE GANESH REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2023 12.66
-22.76
Mar2022 16.39
-22.25
Mar2021 21.08
385.71
Mar2020 4.34
-11.07
Mar2019 4.88 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare EV/Core EBITDA ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹787.5 Cr -1.6% -8.6% 103.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 2.6% -4.7% 54.7% Stock Analytics
CIPLA ₹113,132.0 Cr 4.4% -4.4% 54.7% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 5.8% 17.7% 24.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 5.7% 2.7% 29.3% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 0.4% -5.4% 82.7% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

-1.6%

-8.6%

103.8%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses